We are live on
!
Find out more
PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$3.38B
1-Year Est. Return
14.09%
This Fund
S&P 500
This Quarter
Est. Return
+4.91%
1 Year Est. Return
+14.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.6B
AUM Growth
+$670M
(+23%)
Cap. Flow
+$559M
Cap. Flow
% of AUM
15.51%
Top 10 Holdings %
Top 10 Hldgs %
16.11%
Holding
2,193
New
624
Increased
517
Reduced
333
Closed
712
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$50.1M |
| 2 |
Union Pacific
UNP
|
+$23.2M |
| 3 |
Booking.com
BKNG
|
+$20.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$20.6M |
| 5 |
Boston Scientific
BSX
|
+$20M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$124M |
| 2 |
Cigna
CI
|
+$26.3M |
| 3 |
Lowe's Companies
LOW
|
+$26M |
| 4 |
Visa
V
|
+$24.5M |
| 5 |
UnitedHealth
UNH
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.68% |
| 2 | Healthcare | 7.32% |
| 3 | Consumer Discretionary | 7.26% |
| 4 | Financials | 6.68% |
| 5 | Industrials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Alto Ingredients
ALTO
$326M
| $104K | ﹤0.01% |
+36,137
| New | +$68.9K |
|
1202
Douglas Elliman
DOUG
$183M
| $104K | ﹤0.01% |
46,759
+43,188
| +1,209% | +$119K |
|
1203
CALL
Intercontinental Exchange
ICE
$87.2B
| $102K | ﹤0.01% |
900
-1,500
| -63% | -$162K |
|
1204
Entravision Communication
EVC
$820M
| $101K | ﹤0.01% |
23,053
+19,023
| +472% | +$96.9K |
|
1205
PUT
PG&E
PCG
$38.5B
| $100K | ﹤0.01% |
5,800
-25,500
| -81% | -$432K |
|
1206
Xerox
XRX
$412M
| $99.9K | ﹤0.01% |
+6,710
| New | +$98.2K |
|
1207
EverQuote
EVER
$864M
| $99.6K | ﹤0.01% |
+15,325
| New | +$129K |
|
1208
CALL
M&T Bank
MTB
$36.6B
| $99K | ﹤0.01% |
800
-1,100
| -58% | -$133K |
|
1209
Gates Industrial Corporation Ltd.
GTES
$7B
| $98.6K | ﹤0.01% |
7,316
+5,851
| +399% | +$75.9K |
|
1210
PUT
Roper Technologies
ROP
$39.3B
| $96.2K | ﹤0.01% |
200
+100
| +100% | +$45.3K |
|
1211
CALL
Cardinal Health
CAH
$53.8B
| $94.6K | ﹤0.01% |
+1,000
| New | +$84.5K |
|
|
GRMN
1212
CALL
Garmin
GRMN
$60.2B
| $93.9K | ﹤0.01% |
+900
| New | +$92K |
|
1213
Cannae Holdings
CNNE
$675M
| $93.6K | ﹤0.01% |
+4,633
| New | +$89K |
|
1214
Comtech Telecommunications
CMTL
$52.7M
| $93.4K | ﹤0.01% |
+10,214
| New | +$110K |
|
1215
PUT
SBA Communications
SBAC
$19.8B
| $92.7K | ﹤0.01% |
400
+200
| +100% | +$47.8K |
|
1216
Fulgent Genetics
FLGT
$513M
| $92.5K | ﹤0.01% |
2,497
+1,789
| +253% | +$62.4K |
|
|
KZR
1217
DELISTED
Kezar Life Sciences
KZR
| $91.9K | ﹤0.01% |
3,752
+1,324
| +55% | +$34.5K |
|
1218
FS KKR Capital
FSK
$3.49B
| $91.9K | ﹤0.01% |
+4,789
| New | +$90.6K |
|
1219
Pathward Financial
CASH
$1.79B
| $91.1K | ﹤0.01% |
+1,964
| New | +$88.1K |
|
|
1220
PUT
Intercontinental Exchange
ICE
$87.2B
| $90.5K | ﹤0.01% |
800
-4,100
| -84% | -$444K |
|
1221
BioCryst Pharmaceuticals
BCRX
$2.51B
| $89.8K | ﹤0.01% |
12,755
-2,300
| -15% | -$18.5K |
|
1222
CALL
Paychex
PAYX
$44.6B
| $89.5K | ﹤0.01% |
800
-4,400
| -85% | -$481K |
|
1223
CALL
CBRE Group
CBRE
$44B
| $88.8K | ﹤0.01% |
+1,100
| New | +$82.4K |
|
1224
Woodward
WWD
$21.2B
| $87.6K | ﹤0.01% |
737
-7,026
| -91% | -$744K |
|
1225
1st Source
SRCE
$2.13B
| $87.6K | ﹤0.01% |
+2,088
| New | +$89.8K |
|
Similar funds
CC
SS
GW
WMSA
GC
WP
BWM
DI
Point72 Middle East FZE's Q2 2023 Portfolio in Review
As of Q2 2023, Point72 Middle East FZE held 2,193 positions worth $3.6B, up 23% from $2.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point72 Middle East FZE deployed $559M of net new capital in Q2 2023, opening 624 new positions and adding to 517 existing holdings. Its largest new stake was AbbVie: 129,855 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $21.6M trimmed.
- Point72 Middle East FZE's largest Q2 2023 buy was AbbVie: 129,855 shares worth $17.5M.
- Point72 Middle East FZE added most to iShares Russell 2000 ETF in Q2 2023, an estimated $50.1M increase.
- Point72 Middle East FZE's biggest Q2 2023 reduction was Honeywell, cutting an estimated $21.6M.
- Point72 Middle East FZE fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $124M.
- Point72 Middle East FZE's ten largest holdings make up 16% of its $3.6B portfolio in Q2 2023.
- Point72 Middle East FZE opened 624 new positions and closed 712 in Q2 2023.
- Point72 Middle East FZE's portfolio value rose 23% quarter-over-quarter to $3.6B.
Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.